Moreover, in our ROC curve analysis, the sensitivity of the plasma apoA2-ATQ/AT level for detecting resectable PC was demonstrated to be 41.2% (95% CI: 18.4–67.1%) (40.6% after adjusting for bias) (Table 4). The gene discussed is APOA2; the disease is pachyonychia congenita.